Search results
Results from the WOW.Com Content Network
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
ADHD prescription rates have historically been lower for women than men ... (an ADHD medication marketed under brand names like Ritalin and Concerta) than boys (55.8% vs. 69.7%, respectively ...
A 2006 study in the American Journal of Psychiatry found that the ratio of adult men diagnosed with ADHD to adult women diagnosed with ADHD was about 1.6 to 1. According to experts, the breakdown ...
Common side effects include abdominal pain, loss of appetite, and fever. [3] Serious side effects may include psychosis, sudden cardiac death, mania, anaphylaxis, seizures, and dangerously prolonged erection. [3] Safety during pregnancy and breastfeeding is unclear. [5] Dexmethylphenidate is a central nervous system (CNS) stimulant.
The most comprehensive meta-analysis available (19 studies with over 3.9 million participants) found "no statistically significant association between ADHD medications [including methylphenidate] and the risk of cardiovascular event among children and adolescents, young and middle-aged adults, or older adults"; [44] as do other systematic ...
Over just two years, between 2020-2022, the incidence of ADHD diagnoses in women ages 23 to 49 nearly doubled, contributing to an ongoing medication shortage in the United States.
Viloxazine is indicated to treat attention deficit hyperactivity disorder (ADHD) in children age 6 to 12 years, adolescents age 13 to 17 years, and adults. [1]Analyses of clinical trial data suggest that viloxazine produces moderate reductions in symptoms; it is about as effective as atomoxetine and methylphenidate but with fewer side effects.
But even with a prescription, a recent CDC report shows nearly three quarters of ADHD patients prescribed stimulant drugs are reporting difficulty getting the medications due to ongoing shortages.